These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31965934)

  • 1. A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery.
    Macedo A; Filipe P; Thomé NG; Vieira J; Oliveira C; Teodósio C; Ferreira R; Roque L; Fonte P
    Curr Mol Med; 2020; 20(2):134-143. PubMed ID: 31965934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral insulin delivery: existing barriers and current counter-strategies.
    Gedawy A; Martinez J; Al-Salami H; Dass CR
    J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral insulin delivery: how far are we?
    Fonte P; Araújo F; Reis S; Sarmento B
    J Diabetes Sci Technol; 2013 Mar; 7(2):520-31. PubMed ID: 23567010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal uptake of insulin nanoparticles: facts or myths?
    Lopes MA; Abrahim BA; Seiça R; Veiga F; Rodrigues CR; Ribeiro AJ
    Curr Pharm Biotechnol; 2014; 15(7):629-38. PubMed ID: 25219866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue targeted nanocapsids for oral insulin delivery via drink.
    Chen CC; Baikoghli MA; Cheng RH
    Pharm Pat Anal; 2018 May; 7(3):121-127. PubMed ID: 29676653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds.
    Del Curto MD; Maroni A; Palugan L; Zema L; Gazzaniga A; Sangalli ME
    J Pharm Sci; 2011 Aug; 100(8):3251-3259. PubMed ID: 21465487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
    Xia CQ; Wang J; Shen WC
    J Pharmacol Exp Ther; 2000 Nov; 295(2):594-600. PubMed ID: 11046093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
    Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer.
    Kavimandan NJ; Peppas NA
    Int J Pharm; 2008 Apr; 354(1-2):143-8. PubMed ID: 18262739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats.
    Xia CQ; Shen WC
    Pharm Res; 2001 Feb; 18(2):191-5. PubMed ID: 11405290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative routes of insulin delivery.
    Krishnankutty RK; Mathew A; Sedimbi SK; Suryanarayan S; Sanjeevi CB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 34(10):933-48. PubMed ID: 19893243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies.
    Rehmani S; Dixon JE
    Peptides; 2018 Feb; 100():24-35. PubMed ID: 29412825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography imaging for study of intestinal insulin absorption.
    Park K
    J Control Release; 2010 Aug; 146(1):1. PubMed ID: 20627113
    [No Abstract]   [Full Text] [Related]  

  • 18. The physiological rationale for oral insulin administration.
    Arbit E
    Diabetes Technol Ther; 2004 Aug; 6(4):510-7. PubMed ID: 15321008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of inhaled insulin.
    Mastrandrea LD; Quattrin T
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies to improve the intranasal absorption of insulin.
    Duan X; Mao S
    Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.